Coastwise Capital Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Coastwise Capital Group's PFE Position: Q2 2026 in Review
Coastwise Capital Group increased its Pfizer (PFE) stake by 5.4% in Q2 2026, buying an estimated $107K and bringing the position to 80,028 shares worth $1.93M. The position accounts for 1.12% of the portfolio, ranked #17.
Coastwise Capital Group first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.13M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Coastwise Capital Group held 80,028 shares of Pfizer worth $1.93M as of Q2 2026.
- Coastwise Capital Group bought 4,074 Pfizer shares in Q2 2026, an estimated $107K.
- Pfizer made up 1.12% of Coastwise Capital Group's portfolio in Q2 2026, its #17 holding.
- Coastwise Capital Group first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
- Coastwise Capital Group's Pfizer position peaked at $2.13M in Q1 2026.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.